Product Name :
Sunitinib-d4
Description:
Sunitinib-d4 (SU 11248-d4) is the deuterium labeled Sunitinib. Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation.
CAS:
1126721-79-6
Molecular Weight:
402.50
Formula:
C22H27FN4O2
Chemical Name:
N-[2-(diethylamino)(1,1,2,2-²H₄)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide
Smiles :
[2H]C([2H])(N(CC)CC)C([2H])([2H])NC(=O)C1C(C)=C(/C=C2/C3=CC(F)=CC=C3NC/2=O)NC=1C
InChiKey:
WINHZLLDWRZWRT-IMVYMHHKSA-N
InChi :
InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-/i9D2,10D2
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Sunitinib-d4 (SU 11248-d4) is the deuterium labeled Sunitinib. Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation.{{Onvansertib} web|{Onvansertib} Cell Cycle/DNA Damage|{Onvansertib} Purity & Documentation|{Onvansertib} Formula|{Onvansertib} manufacturer|{Onvansertib} Autophagy} |Product information|CAS Number: 1126721-79-6|Molecular Weight: 402.50|Formula: C22H27FN4O2|Chemical Name: N-[2-(diethylamino)(1,1,2,2-²H₄)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide|Smiles: [2H]C([2H])(N(CC)CC)C([2H])([2H])NC(=O)C1C(C)=C(/C=C2/C3=CC(F)=CC=C3NC/2=O)NC=1C|InChiKey: WINHZLLDWRZWRT-IMVYMHHKSA-N|InChi: InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-/i9D2,10D2|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Rosiglitazone} MedChemExpress|{Rosiglitazone} Metabolic Enzyme/Protease|{Rosiglitazone} Protocol|{Rosiglitazone} In stock|{Rosiglitazone} supplier|{Rosiglitazone} Autophagy} |Shelf Life: ≥12 months if stored properly.PMID:23800738 |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.|Products are for research use only. Not for human use.|